Pyxis Oncology, Inc.·4

Apr 15, 7:58 PM ET

Feingold Jay 4

4 · Pyxis Oncology, Inc. · Filed Apr 15, 2022

Insider Transaction Report

Form 4
Period: 2022-04-14
Feingold Jay
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-04-14+115,931466,611 total
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") that vest on April 13, 2023, subject to the Reporting Person's continued employment through the vesting date.
  • [F2]The Compensation Committee also approved a grant to the Reporting Person, effective January 3, 2023, of an additional 53,931 RSUs that vest on April 13, 2023, subject to the Reporting Person's continued employment through the grant and vesting dates.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4